A detailed history of Adar1 Capital Management, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 22,000 shares of ZLAB stock, worth $678,700. This represents 0.07% of its overall portfolio holdings.

Number of Shares
22,000
Previous 22,000 -0.0%
Holding current value
$678,700
Previous $352 Million 8.18%
% of portfolio
0.07%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$15.95 - $26.8 $31,900 - $53,600
2,000 Added 10.0%
22,000 $352 Million
Q4 2023

Feb 14, 2024

BUY
$22.97 - $30.58 $459,400 - $611,600
20,000 New
20,000 $547 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.